MedTrace Logo

A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting

NCT02331030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-07-19

No results posted yet for this study

Summary

This study evaluates the addition of Pecs II block to ultrasound-guided supraclavicular brachial plexus block in patients undergoing arteriovenous graft creation surgery. Participants will be randomised into two equal groups, one receiving supraclavicular and pecs II blocks, the other receiving supraclavicular block and sham block (Grade 1).

Conditions

  • Arteriovenous Fistula
  • Arteriovenous Graft
  • Kidney Failure, Chronic
  • Renal Failure, End-stage

Interventions

PROCEDURE

Supraclavicular

Ultrasound-guided supraclavicular brachial plexus block

PROCEDURE

Pecs II block

Ultrasound guided interfascial plane block between pectoralis minor and serratus anterior

PROCEDURE

Sham block (Grade 1)

Sham block -- with skin preparation, ultrasound scanning of pecs II block area, but no actual needle injection

DRUG

Ropivacaine 0.5% 20ml

Local anaesthetic solution administered for supraclavicular block

DRUG

Ropivacaine 0.5% 10ml

Local anaesthetic solution administered for pecs II block

Sponsors & Collaborators

  • Changi General Hospital

    lead OTHER

Principal Investigators

  • Kelvin Quek, MMED (Anaes) · Changi General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02331030 on ClinicalTrials.gov